Literature DB >> 8706658

Molecular cloning, expression and characterization of mouse leukotriene C4 synthase.

B K Lam1, J F Penrose, J Rokach, K Xu, M H Baldasaro, K F Austen.   

Abstract

Leukotriene C4 synthase (EC 2.5.1.37) catalyzes the conjugation of reduced glutathione (GSH) with leukotriene A4 to form the intracellular parent of the proinflammatory cysteinyl leukotrienes. Human leukotriene C4 synthase shares substantial amino acid identity in its consensus N-terminal two-thirds with 5-lipoxygenase-activating protein and has a region (residues 37-58) that exhibits 46% amino acid identity with a domain of this protein (residues 41 -62) to which an inhibitor binds. We have now cloned mouse leukotriene C4 synthase CDNA using the polymerase chain reaction to screen a mouse pcDNA3 expression library with oligonucleotide primers based on the translated human leukotriene C4 synthase cDNA sequence. Mouse leukotriene C4 synthase cDNA is 667 bp in length, including the poly(A)-rich tail, and shows 87% similarity with the human cDNA within the open reading frame. The deduced 150-amino-acid sequence of mouse leukotriene C4 synthase (differs from the human enzyme by only 18 amino acids, of which 9 reside at the C terminus. The potential N-glycosylation site, two protein kinase C phosphorylation sites, the two cysteine residues, and the putative inhibitor-binding domain (substitutions Thr4l-->Ser and Tyr50-->Phe) were conserved in mouse leukotriene C4 synthase. Northern blot analysis indicated that the leukotriene C4 synthase RNA transcript is widely distributed. The Km values for leukotriene A4 methyl ester, leukotriene A4 free acid and GSH were 7.6 microM, 3.6 microM and 1.6 mM, respectively, for purified human recombinant enzyme, and 10.3 microM, 2.5 microM and 1.9 microM, respectively, for purified recombinant mouse enzyme; the corresponding Vmax values were 2.5, 1.3 and 2.7 micromol x min(-1) x mg(-1) protein, respectively, for human enzyme, and 2.3, 1.2 and 2.2 micromol x min(-1) x mg(-1) protein, respectively, for mouse enzyme. The 5-lipoxygenase-activating-protein inhibitor, MK-886, was active against both human and mouse recombinant leukotriene C4 synthase with IC50 values of 3.1 microM and 2.7 microM respectively. These findings confirm that the leukotriene C4 synthases belong to a gene family that includes the 5-lypoxygenase-activating protein and suggest that the C-terminal domain of leukotriene C4 synthase may not be critical for its conjugation function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8706658     DOI: 10.1111/j.1432-1033.1996.0606w.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

Review 1.  The leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implications.

Authors:  K Frank Austen; Akiko Maekawa; Yoshihide Kanaoka; Joshua A Boyce
Journal:  J Allergy Clin Immunol       Date:  2009-08-03       Impact factor: 10.793

Review 2.  LTC4 synthase. Enzymology, biochemistry, and molecular characterization.

Authors:  J F Penrose
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

3.  14,15-Dehydroleukotriene A4: a specific substrate for leukotriene C4 synthase.

Authors:  A Sala; M Garcia; S Zarini; J C Rossi; G Folco; T Durand
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

4.  Group V secretory phospholipase A2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis.

Authors:  Barbara Balestrieri; Victor W Hsu; Huiya Gilbert; Christina C Leslie; Won K Han; Joseph V Bonventre; Jonathan P Arm
Journal:  J Biol Chem       Date:  2006-01-01       Impact factor: 5.157

5.  Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase.

Authors:  Ulrike Garscha; Erik Romp; Simona Pace; Antonietta Rossi; Veronika Temml; Daniela Schuster; Stefanie König; Jana Gerstmeier; Stefanie Liening; Markus Werner; Heiner Atze; Sandra Wittmann; Christina Weinigel; Silke Rummler; Gerhard K Scriba; Lidia Sautebin; Oliver Werz
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

6.  Human and Mouse Eosinophils Differ in Their Ability to Biosynthesize Eicosanoids, Docosanoids, the Endocannabinoid 2-Arachidonoyl-glycerol and Its Congeners.

Authors:  Anne-Sophie Archambault; Julyanne Brassard; Émilie Bernatchez; Cyril Martin; Vincenzo Di Marzo; Michel Laviolette; Louis-Philippe Boulet; Marie-Renée Blanchet; Nicolas Flamand
Journal:  Cells       Date:  2022-01-02       Impact factor: 6.600

7.  Structure and inhibition of mouse leukotriene C4 synthase.

Authors:  Damian Niegowski; Thea Kleinschmidt; Shabbir Ahmad; Abdul Aziz Qureshi; Michaela Mårback; Agnes Rinaldo-Matthis; Jesper Z Haeggström
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.